Gujarat Themis Biosyn Expands Global Footprint with ₹1,300 Crore Acquisition of MicroBiopharm Japan
Strategic Expansion in the Pharmaceutical Sector Gujarat Themis Biosyn Ltd announced a definitive agreement this week to acquire the Japanese pharmaceutical firm MicroBiopharm Japan Co. Ltd for a total consideration of ₹1,300 crore. This cross-border acquisition, confirmed following a positive market response that saw Gujarat Themis shares climb 2.07% to ₹364.50 on the BSE, marks…